Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -56.53%-627.09K | -326.86%-666.88K | -271.64%-504.36K | 20.37%-1.52M | -290.60%-823.53K | 67.43%-400.63K | 50.95%-156.23K | 6.02%-135.71K | 33.61%-1.9M | 78.32%-210.84K |
| Net income from continuing operations | -0.57%-726.63K | -92.19%-978.57K | -110.79%-1.05M | -11.86%-3.01M | -104.64%-1.28M | 44.98%-722.48K | 6.40%-509.16K | -137.18%-499.63K | 6.47%-2.69M | 46.79%-627.02K |
| Operating gains losses | ---- | ---- | ---- | --24.22K | ---- | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization | 93.99%44K | 40.28%33.64K | 40.66%33.73K | 67.13%95.45K | 3.50%24.82K | -5.40%22.68K | 161.81%23.98K | --23.98K | --57.11K | --23.98K |
| Remuneration paid in stock | -95.46%4.87K | 28.76%88.41K | -71.39%6.95K | 439.65%356.59K | 416.94%156.45K | 548.87%107.19K | 607.84%68.66K | 153.21%24.29K | 893.80%66.08K | 2,322.10%30.27K |
| Other non cashItems | 108.53%2.88K | -574.82%-145.99K | -23.11%252.49K | 2,581.12%822.78K | 320.02%497.34K | 66.30%-33.7K | 412.25%30.75K | 1,384.58%328.39K | -95.05%30.69K | 6.99%118.41K |
| Change In working capital | -78.82%47.8K | 46.22%335.65K | 2,106.64%255.67K | -68.71%199.29K | -199.87%-243.2K | 58.52%225.68K | 6.06%229.55K | -136.89%-12.74K | 203.83%636.85K | 151.89%243.53K |
| -Change in receivables | 412.05%157.45K | -105.12%-8.88K | -19,244.09%-170.23K | 1,107.68%77.23K | -125.69%-44.95K | 57.29%-50.46K | 590.44%173.52K | 94.16%-880 | 104.08%6.4K | 603.29%174.98K |
| -Change in prepaid assets | 53.85%57.26K | 9.01%-99.2K | -258.89%-31.53K | -122.47%-123.37K | -170.93%-71.41K | -81.37%37.22K | -231.30%-109.01K | -88.01%19.85K | 191.91%548.92K | -70.16%100.68K |
| -Change in payables and accrued expense | -169.86%-166.9K | 168.86%443.73K | 1,542.71%457.43K | 201.01%245.42K | -294.79%-126.83K | 293.34%238.92K | -2.22%165.04K | 72.63%-31.71K | -42.09%81.53K | 84.40%-32.13K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -56.53%-627.09K | -326.86%-666.88K | -271.64%-504.36K | 20.37%-1.52M | -290.60%-823.53K | 67.43%-400.63K | 50.95%-156.23K | 6.02%-135.71K | 33.61%-1.9M | 78.32%-210.84K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | |||||||||
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 68.85%509.62K | 106.77%759.89K | 754.11%196.62K | 50.09%1.9M | 2,563.04%1.21M | -23.22%301.82K | -55.61%367.5K | 2,202.00%23.02K | -52.50%1.27M | -59.07%45.43K |
| Net issuance payments of debt | -195.63%-81.24K | -176.93%-75.82K | -162.54%-71.88K | -146.36%-160.54K | -185.96%-78.3K | -0.37%-27.48K | -163.17%-27.38K | ---27.38K | ---65.16K | ---27.38K |
| Net common stock issuance | 93.31%636.57K | 180.13%1.18M | --0 | 69.06%2.2M | --1.4M | -30.29%329.3K | -49.25%420.7K | --52K | -56.44%1.3M | --0 |
| Proceeds from stock option exercised by employees | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| Net other financing activities | ---45.71K | -1,227.59%-342.78K | 16,881.25%268.5K | -539.66%-137.31K | -250.92%-109.89K | --0 | -375.85%-25.82K | -260.00%-1.6K | 109.50%31.23K | --72.81K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 68.85%509.62K | 106.77%759.89K | 754.11%196.62K | 50.09%1.9M | 2,563.04%1.21M | -23.22%301.82K | -55.61%367.5K | 2,202.00%23.02K | -52.50%1.27M | -59.07%45.43K |
| Net cash flow | ||||||||||
| Beginning cash position | 26.87%343.55K | 320.91%250.54K | 224.18%558.28K | -78.71%172.21K | -49.06%171.99K | -76.95%270.8K | -91.06%59.52K | -78.71%172.21K | -19.65%808.83K | -79.79%337.62K |
| Current changes in cash | -18.88%-117.47K | -55.97%93.02K | -173.08%-307.74K | 160.64%386.06K | 333.54%386.29K | 88.20%-98.81K | -58.52%211.28K | 21.41%-112.69K | -221.81%-636.62K | 80.80%-165.41K |
| End cash Position | 31.45%226.08K | 26.87%343.55K | 320.91%250.54K | 224.18%558.28K | 224.18%558.28K | -49.06%171.99K | -76.95%270.8K | -91.06%59.52K | -78.71%172.21K | -78.71%172.21K |
| Free cash from | -56.53%-627.09K | -326.86%-666.88K | -271.64%-504.36K | 20.37%-1.52M | -290.60%-823.53K | 67.43%-400.63K | 50.95%-156.23K | 6.02%-135.71K | 33.61%-1.9M | 78.32%-210.84K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.